Wasatch Advisors’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-83,005
Closed -$6.55M 286
2020
Q4
$6.55M Sell
83,005
-249,460
-75% -$14.6M 0.03% 200
2020
Q3
$14.6M Sell
332,465
-1,496,151
-82% -$73.7M 0.09% 149
2020
Q2
$80.9M Sell
1,828,616
-179,226
-9% -$6.69M 0.59% 61
2020
Q1
$72.1M Sell
2,007,842
-605,653
-23% -$34.4M 0.75% 49
2019
Q4
$185M Buy
2,613,495
+231,211
+10% +$16.8M 1.52% 15
2019
Q3
$178M Buy
2,382,284
+101,533
+4% +$8.61M 1.7% 13
2019
Q2
$184M Buy
2,280,751
+264,051
+13% +$18.6M 1.79% 9
2019
Q1
$135M Buy
2,016,700
+28,610
+1% +$2.17M 1.47% 21
2018
Q4
$148M Buy
1,988,090
+38,382
+2% +$3.17M 1.97% 11
2018
Q3
$179M Buy
1,949,708
+176,716
+10% +$16.8M 2.05% 8
2018
Q2
$174M Buy
1,772,992
+289,614
+20% +$32.4M 2.1% 9
2018
Q1
$165M Buy
1,483,378
+306,621
+26% +$34.4M 2.14% 8
2017
Q4
$121M Buy
1,176,757
+639,976
+119% +$63.7M 1.61% 15
2017
Q3
$50.5M Buy
+536,781
New +$42.4M 0.69% 52

Other funds holding CMD

Wasatch Advisors's CMD Position: Q1 2021 in Review

Wasatch Advisors sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 83,005 shares — an estimated $6.55M sold.

Wasatch Advisors first reported a position in CMD in Q3 2017 and held it in 14 quarters. The position peaked at $185M in Q4 2019. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

  • Wasatch Advisors reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
  • Wasatch Advisors sold 83,005 Cantel Medical Corporation shares in Q1 2021, an estimated $6.55M.
  • Wasatch Advisors first reported a position in Cantel Medical Corporation in Q3 2017 and held it in 14 quarters.
  • Wasatch Advisors's Cantel Medical Corporation position peaked at $185M in Q4 2019.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on Wasatch Advisors's 13F filing for Q1 2021, filed 10 May 2021.